The case of a woman who developed atypical hemolytic uremic syndrome (aHUS) following pregnancy highlights the importance of an…
Articles by Marisa Wexler, MS
Complement-blocking medications like Soliris (eculizumab) can be effective for controlling atypical hemolytic uremic syndrome (aHUS) in patients carrying…
The safety profile of Soliris (eculizumab) in real-world practice is similar to that reported in clinical trials, according to…
Most patients and caregivers living with atypical hemolytic uremic syndrome (aHUS) prefer Ultomiris (ravulizumab-cwvz) over Soliris (eculizumab),…
A case study of atypical hemolytic uremic syndrome (aHUS) caused by a new mutation in the DGKE gene highlights…
A young adult with atypical hemolytic uremic syndrome (aHUS) in India successfully received a transplanted kidney from a donor…
A boy with atypical hemolytic uremic syndrome (aHUS) experienced a disease relapse followed by unusual symptoms, including bone tissue…
People with atypical hemolytic uremic syndrome (aHUS) who start treatment with Soliris (eculizumab) or Ultomiris (ravulizumab) —…
For the first time in South Korea, a patient who developed atypical hemolytic uremic syndrome (aHUS) after undergoing a…
About half of the atypical hemolytic uremic syndrome (aHUS) patients had clinically relevant anxiety and more than a quarter…